Editas Medicine EDIT
NASDAQ EDIT
$2.38 -0.13 (-4.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Editas Medicine (EDIT) Price to FCF (2017)

Updated

Editas Medicine's Price to FCF came in at 65.36 for Q2 2017, up 86.8% from the prior quarter.

Analysis

Editas Medicine (EDIT) Price to FCF (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Editas Medicine 385.55 Mn -286.59 Mn 8.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 65.36
Mar 31, 2017 34.99
API Access

Editas Medicine Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=EDIT&period=max&api_key=YOUR_API_KEY